Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection
- PMID: 20056835
- PMCID: PMC2808084
- DOI: 10.2353/ajpath.2010.090634
Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection
Abstract
Alternative macrophage activation is associated with exacerbated disease in murine models of pulmonary cryptococcosis. The present study evaluated the efficacy of interferon-gamma transgene expression by Cryptococcus neoformans strain H99gamma in abrogating alternative macrophage activation in infected mice. Macrophage recruitment into the lungs of mice after infection with C. neoformans strain H99gamma was comparable with that observed in mice challenged with wild-type C. neoformans. However, pulmonary infection in mice with C. neoformans strain H99gamma was associated with reduced pulmonary fungal burden, increased pulmonary Th1-type and interleukin-17 cytokine production, and classical macrophage activation as evidenced by increased inducible nitric oxide synthase expression, histological evidence of enhanced macrophage fungicidal activity, and resolution of inflammation. In contrast, progressive pulmonary infection, enhanced Th2-type cytokine production, and the induction of alternatively activated macrophages expressing arginase-1, found in inflammatory zone 1, Ym1, and macrophage mannose receptor were observed in the lungs of mice infected with wild-type C. neoformans. These alternatively activated macrophages were also shown to harbor highly encapsulated, replicating cryptococci. Our results demonstrate that pulmonary infection with C. neoformans strain H99gamma results in the induction of classically activated macrophages and promotes fungal clearance. These studies indicate that phenotype, as opposed to quantity, of infiltrating macrophages correlates with protection against pulmonary C. neoformans infection.
Figures










Similar articles
-
Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.J Immunol. 2012 Oct 15;189(8):4060-8. doi: 10.4049/jimmunol.1103455. Epub 2012 Sep 14. J Immunol. 2012. PMID: 22984078 Free PMC article.
-
Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.Infect Immun. 2010 Dec;78(12):5341-51. doi: 10.1128/IAI.00845-10. Epub 2010 Oct 4. Infect Immun. 2010. PMID: 20921149 Free PMC article.
-
STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.J Immunol. 2014 Oct 15;193(8):4060-71. doi: 10.4049/jimmunol.1400318. Epub 2014 Sep 8. J Immunol. 2014. PMID: 25200956 Free PMC article.
-
Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections.Mucosal Immunol. 2014 Sep;7(5):1023-35. doi: 10.1038/mi.2014.65. Epub 2014 Jul 30. Mucosal Immunol. 2014. PMID: 25073676 Review.
-
Regulating the T-cell immune response toward the H99 strain of Cryptococcus neoformans.Am J Pathol. 2009 Dec;175(6):2255-6. doi: 10.2353/ajpath.2009.090891. Epub 2009 Oct 29. Am J Pathol. 2009. PMID: 19875503 Free PMC article. Review.
Cited by
-
Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection.mBio. 2013 Jun 18;4(3):e00264-13. doi: 10.1128/mBio.00264-13. mBio. 2013. PMID: 23781069 Free PMC article.
-
Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis.mBio. 2012 Sep 25;3(5):e00196-12. doi: 10.1128/mBio.00196-12. Print 2012. mBio. 2012. PMID: 23015735 Free PMC article.
-
IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.Am J Pathol. 2012 Apr;180(4):1547-59. doi: 10.1016/j.ajpath.2011.12.038. Epub 2012 Feb 16. Am J Pathol. 2012. PMID: 22342846 Free PMC article.
-
IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.PLoS Pathog. 2018 Oct 10;14(10):e1007358. doi: 10.1371/journal.ppat.1007358. eCollection 2018 Oct. PLoS Pathog. 2018. PMID: 30304063 Free PMC article.
-
Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome.Front Microbiol. 2016 Feb 9;7:105. doi: 10.3389/fmicb.2016.00105. eCollection 2016. Front Microbiol. 2016. PMID: 26903984 Free PMC article. Review.
References
-
- Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis. 1993;17:837–842. - PubMed
-
- Arora S, Hernandez Y, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Role of IFN-γ in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis. J Immunol. 2005;174:6346–6356. - PubMed
-
- Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol. 1992;22:1447–1454. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous